Surrozen, Inc.

NASDAQ:SRZN

Biotechnology

Healthcare
$30.67 -4.74%

-$1.14 today

Market cap
$229.33M
Beta
0.51
P/E (TTM)
-0.7
EPS (TTM)
-$31.29
52W Low $8.00High $35.00

Volume 0.09M

Average 0.11M

Balance Sheet

Inspect the capital base behind the business.

Assets

$98.73M

FY 2025 · Annual

+103.7% YoY

Liabilities

$286.49M

FY 2025 · Annual

+310.2% YoY

Equity

-$187.76M

FY 2025 · Annual

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents33.09M24.69M36.04M34.57M89.25M
Short-term Investments68.76M51.15M000
Net Receivables01.98M2.15M2.54M208K
Inventory00000
Other Current Assets0756K580K671K2.11M
Total Current Assets105.19M81.31M41.13M38.93M91.56M
Property, Plant & Equipment (Net)9.38M6.9M3.86M8.36M6.43M
Goodwill00000
Intangible Assets00000
Long-term Investments21.66M0688K0688K
Tax Assets00000
Other Non-current Assets954K1.23M402K1.17M46K
Total Non-current Assets31.99M8.13M4.95M9.54M7.17M
Total Assets137.17M89.44M46.08M48.47M98.73M
Account Payables2.72M658K525K306K728K
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities589K581K292K191K289K
Total Current Liabilities13.57M9.73M7.15M7.32M9.93M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities8.3M326K115K55.89M271.21M
Total Non-current Liabilities13.9M3.7M997K62.53M276.56M
Total Liabilities27.47M13.43M8.15M69.85M286.49M
Common Stock4K0001K
Retained Earnings(142.65M)(178.65M)(221.7M)(285.26M)(527.29M)
Accumulated OCI(119K)(241K)000
Other Stockholders Equity00000
Minority Interest00000
Total Equity109.7M76M37.94M(21.38M)(187.76M)
Total Debt7.79M5.6M3.38M8.47M6.64M
Net Debt(25.3M)(19.09M)(32.66M)(26.1M)(82.61M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$106.9M
Receivables$5.0M
Other Current$2.0M
Total Current Assets$113.9M
PP&E (Net)$6.0M
Long-term Investments$688.0K
Other Non-current$34.0K
Total Non-current Assets$6.8M
Total Assets$120.7M

Analysis

Selected assets total $120.7M for Latest. The largest visible component is Cash & Equivalents at $106.9M, about 88.6% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
FWPFWP filingNov 13, 2026
SC 13G/ASC 13G/A filingNov 13, 2026
8-KCurrent reportNov 9, 2026
10-QQuarterly reportNov 9, 2026
SC 13D/ASC 13D/A filingNov 6, 2026

How much cash does SRZN have?

Surrozen, Inc. (SRZN) reported $89.25M in cash and equivalents in fiscal 2025.

How much debt does SRZN carry?

Surrozen, Inc. (SRZN) reported $6.64M of total debt, with net debt of -$82.61M.